Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Avigdor

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|March 11, 2020
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patientsOrit Itzhaki, Elad Jacoby, Abraham Nissani, et al.
Leukemia & Lymphoma|September 16, 2022
Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucelShalev Fried, Roni Shouval, Nira Varda-Bloom, et al.
American Journal of Hematology|September 7, 2018
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemiaElad Jacoby, Bella Bielorai, Abraham Avigdor, et al.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Blood Advances|December 19, 2023
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)Tycel J Phillips, Abraham Avigdor, Ronit Gurion, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
The Journal of Clinical Investigation|February 7, 2009
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilizationYaron Vagima, Abraham Avigdor, Polina Goichberg, et al.
Cells|April 12, 2022
Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell MalignanciesKatia Beider, Orit Itzhaki, Jacob Schachter, et al.
Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Open Forum Infectious Diseases|October 9, 2023
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal AntibodiesNadav Furie, Michal Mandelboim, Neta Zuckerman, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|March 11, 2020
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patientsOrit Itzhaki, Elad Jacoby, Abraham Nissani, et al.
Leukemia & Lymphoma|September 16, 2022
Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucelShalev Fried, Roni Shouval, Nira Varda-Bloom, et al.
American Journal of Hematology|September 7, 2018
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemiaElad Jacoby, Bella Bielorai, Abraham Avigdor, et al.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Blood Advances|December 19, 2023
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)Tycel J Phillips, Abraham Avigdor, Ronit Gurion, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
The Journal of Clinical Investigation|February 7, 2009
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilizationYaron Vagima, Abraham Avigdor, Polina Goichberg, et al.
Cells|April 12, 2022
Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell MalignanciesKatia Beider, Orit Itzhaki, Jacob Schachter, et al.
Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Open Forum Infectious Diseases|October 9, 2023
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal AntibodiesNadav Furie, Michal Mandelboim, Neta Zuckerman, et al.
Pageof 12